OVERVIEW

Community Practice Connections™: Navigating Treatment Sequencing in Pancreatic Cancer: Experts Paving the Road Toward Patient-Centric Care is organized by Physicians' Education Resource, LLC (PER)

Release Date: August 30, 2019
Expiration Date: August 30, 2020

Target Audience:
This educational activity is directed toward medical oncologists, gastroenterologists, gastrointestinal oncologists, and surgical oncologists who treat patients with pancreatic cancer. Other healthcare professionals who have an interest in the treatment of pancreatic cancer, such as endocrinologists, nurses, physician assistants, fellows, and residents, are also invited to participate.

Accreditation/Credit Designation:
Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Overview:
Pancreatic adenocarcinoma remains among the most challenging malignancies to treat, but with ongoing clinical research comes the continual potential for improvements in patient care and outcomes. In this online activity, Navigating Treatment Sequencing in Pancreatic Cancer: Experts Paving the Road Towards Patient-Centric Care, the latest cutting-edge data will be presented within a framework of patient cases. The experts in pancreatic cancer management will discuss evidence-based, guideline-recommended therapies and potential drug sequencing; the differential clinical profiles of the available treatments, including adverse event as well as pharmacodynamic and pharmacokinetic profiles; and the latest clinical trial developments in the evolving treatment landscape for pancreatic cancer. During this activity, interactive questions interspersed throughout case presentations will give you the opportunity to identify and reflect on the optimal management of pancreatic cancer and how to integrate emerging options into the plan of care for your patients.

Learning Objectives:
Upon successful completion of this educational activity, you should be better prepared to:
• Outline the scientific rationale for the use of current pancreatic cancer agents/regimens.
• Summarize recent best practices for individualized, patient-centric approaches to care, including approaches for treatment sequencing in pancreatic cancer.
• Evaluate the latest clinical trial data of approved and investigational agents in the context of evolving treatment paradigms in the field of pancreatic cancer management.
• Discuss mitigation and management of treatment-related toxicities across multiple lines of therapy in patients with pancreatic cancer.